JOEL BEDARD: Open Payments
NPI 1770538191 · HEMPSTEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 10 payments from 5 companies in 2025. Trend: 2023 $132 · 2024 $285 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $85 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
Products named: INGREZZA, CAPLYTA, COBENFY, FANAPT, LYBALVI.
Industry payments across NY — which companies pay providers there.
